Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of High-Efficacy Disease Modifying Treatment of Relapsing Multiple Sclerosis

NCT06159712 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT06159712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06159712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of High-Efficacy Disease Modifying Treatment of Relapsing Multiple Sclerosis
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Unknown status
Start date
November 27, 2023
Completion date
November 30, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing remitting multiple sclerosis